Policy & Advocacy MassBio statement opposing ‘Most Favored Nation’ prescription drug pricing policy May 12, 2025
Press Releases U.S. Biotechnology, Massachusetts Leadership at Risk: New Report Warns of Major Disruption Across Innovation Pipeline May 06, 2025
Policy & Advocacy MassBio Statement on President Trump’s executive order on drug pricing Apr 16, 2025
Press Releases MassBio Recognizes Life Sciences Companies, Leaders with Awards at Annual State of Possible Conference Mar 26, 2025
Policy & Advocacy Statement on CMS listing 15 additional drugs subject to price negotiations Jan 17, 2025
Announcements MassBio Year-End Funding Report: Massachusetts Biopharma Companies Surpass Last Year’s VC Total Jan 07, 2025
